AAM Calls Out Threat Of Consolidation Among Purchasers
Letter To Authorities Accuses Buying Groups And PBMs Of Anticompetitive Activities
Drug buying groups and pharmacy benefit managers are leaving generic drug producers unable to compete even when they have viable products due to concentration of buyer power, the Association for Accessible Medicines has highlighted.
